Central systolic blood pressure (HR 1.50; 95% CI 1.33-1.70) and central pulse pressure were not more strongly associated with cardiovascular endpoints than peripheral measurements.
Cohort (n=5,608)
Sí
Does central pulsatile blood pressure predict cardiovascular endpoints more strongly than peripheral pulsatile blood pressure in a general cohort?
Central blood pressure measurements do not provide stronger prognostic value for cardiovascular endpoints and mortality compared to standard peripheral blood pressure measurements.
Hazard Ratio: 1.5 (95% CI 1.33–1.7)
valor p: p=<0.001
Pulsatile blood pressure (BP) confers cardiovascular risk. Whether associations of cardiovascular end points are tighter for central systolic BP (cSBP) than peripheral systolic BP (pSBP) or central pulse pressure (cPP) than peripheral pulse pressure (pPP) is uncertain. Among 5608 participants (54.1% women; mean age, 54.2 years) enrolled in nine studies, median follow-up was 4.1 years. cSBP and cPP, estimated tonometrically from the radial waveform, averaged 123.7 and 42.5 mm Hg, and pSBP and pPP 134.1 and 53.9 mm Hg. The primary composite cardiovascular end point occurred in 255 participants (4.5%). Across fourths of the cPP distribution, rates increased exponentially (4.1, 5.0, 7.3, and 22.0 per 1000 person-years) with comparable estimates for cSBP, pSBP, and pPP. The multivariable-adjusted hazard ratios, expressing the risk per 1-SD increment in BP, were 1.50 (95% CI, 1.33–1.70) for cSBP, 1.36 (95% CI, 1.19–1.54) for cPP, 1.49 (95% CI, 1.33–1.67) for pSBP, and 1.34 (95% CI, 1.19–1.51) for pPP ( P <0.001). Further adjustment of cSBP and cPP, respectively, for pSBP and pPP, and vice versa, removed the significance of all hazard ratios. Adding cSBP, cPP, pSBP, pPP to a base model including covariables increased the model fit ( P <0.001) with generalized R 2 increments ranging from 0.37% to 0.74% but adding a second BP to a model including already one did not. Analyses of the secondary end points, including total mortality (204 deaths), coronary end points (109) and strokes (89), and various sensitivity analyses produced consistent results. In conclusion, associations of the primary and secondary end points with SBP and pulse pressure were not stronger if BP was measured centrally compared with peripherally.
Huang et al. (Wed,) conducted a cohort in Cardiovascular risk (n=5,608). Central systolic blood pressure (cSBP) and central pulse pressure (cPP) vs. Peripheral systolic blood pressure (pSBP) and peripheral pulse pressure (pPP) was evaluated on Composite cardiovascular end point (HR 1.50, 95% CI 1.33-1.70, p=<0.001). Central systolic blood pressure (HR 1.50; 95% CI 1.33-1.70) and central pulse pressure were not more strongly associated with cardiovascular endpoints than peripheral measurements.